Sofia Mayans, CEO at InfiCure Bio, will participate in the national pitching competition "Hela Sverige Pitchar" by Connect Sverige. InfiCure Bio is one of 5 companies in Life Science/MedTech that will pitch on January 29 [...]

https://www.mynewsdesk.com/se/umeaa-biotech-incubator/pressreleases/inficure-bio-secures-us-patent-and-publishes-new-data-in-a-top-scientific-journal-3060618?utm_source=rss&utm_medium=rss&utm_campaign=Alert&utm_content=pressrelease

Check out our new exciting study describing the liver phenotype of the NIF mouse! We are proud to announce that it has been accepted for publication in Scientific Reports (https://lnkd.in/emhf8h7). In this paper we demonstrate [...]

InfiCure Bio AB will attend the 4th NASH Summit (https://nash-summit.com) in mid December and our CEO Sofia Mayans will give a talk on our unique NIF mouse on December 16th at 2.45pm EST. Do not [...]

Sofia Mayans and Dan Holmberg will attend the Annual AFDD meeting, this year an entirely digital event: https://afdd-summit.com/  

The annual retreat for InfiCure Bio took place last week and we had fruitful and interesting discussions on future progress of the company. Validation of the NIF mouse as a spontaneous liver model is complete [...]